Astrazeneca Pharma India reports standalone net loss of Rs 27.96 crore in the September 2014 quarter

Sales decline 0.89% to Rs 114.55 crore

Net Loss of Astrazeneca Pharma India reported to Rs 27.96 crore in the quarter ended September 2014 as against net loss of Rs 1.23 crore during the previous quarter ended September 2013. Sales declined 0.89% to Rs 114.55 crore in the quarter ended September 2014 as against Rs 115.58 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales114.55115.58 -1 OPM %-22.79-1.49 -PBDT-24.501.62 PL PBT-27.96-0.72 -3783 NP-27.96-1.23 -2173

Powered by Capital Market - Live News